People · Operator
Named in public records as an officer, director or promoter · active 2017–2026 · Biotechnology, Healthtech, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Atomwise Inc. | — | Biotechnology | Series D+ | $238.6M | $124.3M | 2024 |
| Silk Road Medical Inc | — | Healthtech | Series C | $141.7M | $1.1B | 2017 |
| Neocis, Inc. | — | Other Technology | Series C | $119.2M | $2.1B | 2019 |
| Carlsmed, Inc. | — | Biotechnology | Series C | $109.1M | $645.4M | 2022 |
| Volastra Therapeutics, Inc. | — | Biotechnology | Series C | $105.3M | $170.5M | 2025 |
Robert Mittendorff at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert Mittendorff on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jonathan Root | 1 | 16 |
| Ajay Royan | 1 | 13 |
| Matt Ocko | 1 | 13 |
| Amy Schulman | 1 | 11 |
| Noah Knauf | 1 | 9 |
| FRED MOLL | 1 | 8 |
| Tony Chou | 1 | 7 |
| Kevin Sidow | 1 | 7 |
| John Kennedy | 1 | 6 |
| Elizabeth H. Weatherman | 1 | 6 |
| Jack Lasersohn | 1 | 5 |
| Adam Seabrook | 1 | 5 |
| ALEXANDER ARROW | 1 | 5 |
| In Seon Hwang | 1 | 5 |
| David Nicholson | 1 | 5 |
| Kiersten Stead | 1 | 4 |
| Philip Young | 1 | 4 |
| Randy Glein | 1 | 4 |
| Luc Dochez | 1 | 4 |
| Raj Ganguly | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.